期刊文献+

婴儿肥厚型心肌病一家系GAA基因的突变分析 被引量:2

Analysis of the GAA Gene Mutations in a Chinese Family with Infantile Hypertrophic Cardiomyopathy
下载PDF
导出
摘要 【目的】鉴定一个婴儿肥厚型心肌病家系GAA基因的致病性突变。【方法】分析一例患病女婴的临床及家系资料;提取先证者及其父母和姐姐的外周血DNA,PCR扩增GAA基因的全部20个外显子及剪接位点序列,对PCR产物进行直接测序。【结果】家系分析表明该病的遗传方式可能为常染色体隐性遗传;心脏彩超提示患儿有肥厚型心肌病;先证者GAA基因有两个复合杂合性突变:遗传自母亲的外显子13的c.1843G>A(p.G615R)错义突变和遗传自父亲的外显子18的c.2608C>T(p.R870X)无义突变。先证者未患病的姐姐只携带了c.2608C>T杂合性突变。该两种突变均尚未在大陆地区患者中发现。该两个突变已被证实可引起突变等位基因编码的蛋白残存的GAA酶活性严重减少。【结论】GAA基因的c.1843G>A和c.2608C>T复合杂合性突变导致了该患儿出现以肥厚型心肌病为特征的经典婴儿型Pompe病(或糖原贮积症Ⅱ型)。该研究进一步证实了c.1843G>A突变与婴儿型Pompe病相关;同时也表明了对常染色体隐性遗传的婴儿肥厚型心肌病进行GAA基因检测或GAA酶活性检测的必要性。 [ Objective ] To identify pathological mutations of the GAA gene in a Chinese family with two patients affected with infantile hypertrophic cardiomyopathy. [ Methods ] The clinical data and the family history of the proband, a 6-month-old affected female infant, were investigated. DNA was extracted from peripheral blood of the proband, her parents and sister. All 20 exons and the intron-exon splice sites of GAA gene were amplified by polymerase chain reaction (PCR). Mutations were detected by direct sequencing the PCR products. [ Results ] The echocardiography indicated that the infant had hypertrophic cardiomyopathy. Pedigree analysis suggested that the mode of inheritance might be autosomal recessive. The infant was found to be compound heterozygous for two mutations in the GAA gene: c.1843G 〉 A (p.G615R) missense mutation in the exon 13 from her mother and c.2608C 〉 T (p. R870X) nonsense mutation in the exon 18 from her father. The proband's unaffected sister only carried the heterozygous c.2608C 〉 T mutation. The c.1843G〉A mutation was first discovered in the patients with infantile form of Pompe disease in Taiwan, and the c. 2608C〉T mutation was first found in the Argentineans patients and then in the German patients. To the best of our knowledge, this is the first report for the two variants in the GAA gene in the China's Mainland. Both the mutant alleles had been verified to code for the mutant protein with very low GAA activity respectively. [Conclusion] The compound heterozygous c.1843G 〉 A and c.2608C 〉 T mutations caused the infant's condition, the classic infantile form of Pompe disease (or glycogen storage disease type II) characterized by hypertrophic cardiomyopathy. This study confirms that c. 1843G〉A mutation is related to the classic infantile form of Pompe disease. It also indicates the necessity of performing the analysis of the GAA gene or GAA activity for patients with the autosomal reccesive infantile hypertrophic cardiomyopathy.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2014年第1期139-143,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家自然科学基金(81200402)
关键词 肥厚型心肌病 GAA基因 糖原贮积症Ⅱ型 Pompe病 hypertrophic cardiomyopathy GAA gene glycogen storage disease type II Pompe disease
  • 相关文献

参考文献5

二级参考文献44

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2Kostera-Pruszezyk A, Opuehlik A, Lugowska A, et al. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome. Neuromuscul Disord, 2006, 16:282- 285.
  • 3Labrousse P, Chien YH, Pomponio RJ, et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab, 2010, 99; 379-383.
  • 4Huie ML, Chen AS, Tsujino S, et al. Aberrant splicing in adult onset glycogen storage disease type Ⅱ (GSD Ⅱ ) : molecular identification of an IVS1 ( -13T→G) mutation in a majority of patients and a novel IVS10 (+1GT→CT) mutation. Hum Mol Genet, 1994, 3: 2231-2236.
  • 5Becker JA, Vlaeh J, Raben N, et al. The African origin of the common mutation in African American patients with glycogen storage disease type Ⅱ. Am J Hum Genet, 1998, 62:991 -994.
  • 6Tsujino S, Huie M, Kanazawa N, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord, 2000, 10: 599-603.
  • 7Wan L, Lee CC, Hsu CM, et al. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type Ⅱ. J Neurol, 2008, 255: 831-838.
  • 8Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr, 2004, 144:S35 -43.
  • 9McCready ME, Carson NL, Chakraborty P, et al. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type Ⅱ. Mol Genet Metab, 2007, 92: 325-335.
  • 10Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type Ⅱ in New York and estimates of affected individuals born with the disease. Am J Med Genet, 1998, 79: 69-72.

共引文献28

同被引文献35

  • 1傅立军,窦薇,周爱卿,黄美蓉,杨健萍,李奋.糖原累积病Ⅱ型的临床分析和基因学检测[J].临床儿科杂志,2006,24(12):962-965. 被引量:12
  • 2单岩东,王朝东,张昆南.Ⅱ型糖原累积病的研究进展[J].中国临床神经科学,2007,15(2):203-207. 被引量:14
  • 3仇佳晶,魏珉,张为民,施惠平.幼年起病的2例晚发型糖原贮积症Ⅱ型/Pompe病临床和基因分析[J].中华儿科杂志,2007,45(10):760-764. 被引量:11
  • 4Turaca LT, De Faria DO, Kyosen SO, et al. Novel GAA mutations in patients with Pompe disease[J]. Gene, 2015, 561(1) :124-131.
  • 5Crescimanno G,Modica R,Lo Mauro R,et al. Role of the cardio pulmonary exercise test and si~minute walking test in the evaluation of exercise per{ormance in patients with late~onset Pompe disease[J]. Neuromuscul Disord, 2015,25 (7) : 542-547.
  • 6Todd AG, Mcelroy JA, Grange RW, et al. Correcting neu romuscular deficits with gene therapy in pompe disease [J]. Ann Neurol,2015,78(2) :222 234.
  • 7Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type H in New York and esti mates of affected individuals born with the diseaseFJl. Am J Med Genet,1998,79(1) :69-72.
  • 8Lin CY, Shieh JJ. Molecular study on the infantile form of Pompe disease in Chinese in TaiwanEJJ. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 1996,37(2):115- 121.
  • 9Chien YH, Chiang SC, Zhang XK, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program[J1. Pediatrics, 2008, 122(1) : e39-45.
  • 10Liu X,Wang Z,Jin W,et al. Clinical and GAA gene muta- tion analysis in mainland Chinese patients with late-onset Pompe disease : identifying e. 2238G~ C as the most corn mon mutationEJl. BMC Med Genet, 2014,15 ( 1 ) : 141.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部